Boston Scientific Corp
Close on Nov 18, 2026Market cap $63.24BP/E 17.7Yield –
Boston Scientific NIH ClinicalTrials.gov by Year
NIH ClinicalTrials.gov — Target Patient Enrollment in Newly Started BSX Studies (patients)
Boston Scientific NIH ClinicalTrials.gov: 24,772.00 patients in FY2025, up 30.3% from a year earlier.
Where the FY2025 figure comes from
Source: NIH ClinicalTrials.gov Registry — Boston Scientific ↗
Reported in U.S. National Library of Medicine (ClinicalTrials.gov API v2 — Boston Scientific Sponsored Studies).
annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Boston Scientific NIH ClinicalTrials.gov, annual FY2015–FY2025 [Data set]. Compiled from Boston Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/bsx/kpis/ext-ct-enroll
See every metric in the Boston Scientific KPI table. Data updated Nov 4, 2026.
See a number that looks wrong?